United States
Choose your country or region:
France
Germany
Italy
Japan
United Kingdom
About
Leadership
Board of Directors
Company History
Corporate Impact and Community Relations
Health Equity
Our Collaborations
Contact Us
Newsroom
News & Stories
Press Releases
Multimedia
Our Tests
Cologuard®
OncoExTra™
Oncoguard® Liver
Oncotype DX®
Oncotype DX Breast DCIS Score®
Oncotype DX Breast Recurrence Score®
Oncotype DX Colon Recurrence Score®
Riskguard™
Provider
Patient
Pipeline & Data
Breast Radiation Score
Next Generation Cologuard
Colorectal Cancer Blood
LBgard® Blood Tubes
Molecular Residual Disease
Cancerguard™
Our Expertise
Cancerguard™ Science
Multi-Cancer Early Detection Thought Leadership
Clinical Studies
Research
Publications & Abstracts
Exact Academy
Investor Relations
Press Releases
Events & Presentations
Environmental, Social, and Governance (ESG)
Stock Information
Financial Information
Email Alerts
Contact Us
Join Our Team
×
DIGITAL NEWSROOM
Posts in:
Investor Relations
April 15, 2024
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
April 05, 2024
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-cancer
April 04, 2024
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to inform treatment
February 21, 2024
Exact Sciences Announces Fourth Quarter 2023 Results
January 07, 2024
Exact Sciences Announces Preliminary Fourth Quarter 2023 Results
November 01, 2023
Exact Sciences Announces Third-Quarter 2023 Results
September 12, 2023
Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience
August 01, 2023
Exact Sciences Announces Second-Quarter 2023 Results
June 21, 2023
Exact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations
June 20, 2023
Next Generation Cologuard Test Demonstrates 94 Percent Sensitivity for Colorectal Cancer at 91 Percent specificity, Raising the Bar in Non-invasive Screening
May 09, 2023
Exact Sciences Announces First Quarter 2023 Results
February 21, 2023
Exact Sciences Announces Fourth Quarter 2022 Results
1
2
3
4
